Education
About Us
Working with TipRanks
Follow Us
Sensus Healthcare, Inc. (SRTS)
:SRTS
SRTS Stock Chart & Stats
$3.52
-$0.31(-4.45%)
At close: 4:00 PM EST
$3.52
-$0.31(-4.45%)
Day’s Range― - ―
52-Week Range$3.03 - $9.33
Previous CloseN/A
Volume208.66K
Average Volume (3M)126.09K
Market Cap
$69.05M
Enterprise Value$27.33M
Total Cash (Recent Filing)$22.16M
Total Debt (Recent Filing)$595.00K
Price to Earnings (P/E)―
Beta0.83
Next Earnings
Feb 05, 2026EPS Estimate
-0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding16,440,037
10 Day Avg. Volume213,917
30 Day Avg. Volume126,090
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)2.02
Price to Sales (P/S)2.70
P/FCF Ratio-101.97
Enterprise Value/Market Cap0.40
Enterprise Value/Revenue0.73
Enterprise Value/Gross Profit1.39
Enterprise Value/Ebitda-32.96
Forecast
1Y Price Target
$7.33Price Target Upside108.24% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.33
Revenue Forecast (FY)$30.81M
Bulls Say, Bears Say
Bulls Say
Financial PerformanceSensus Healthcare reported 3Q25 results with revenue, gross margin, and GAAP EPS all above consensus estimates.
Reimbursement PoliciesMedicare proposed a physician fee schedule that would significantly increase reimbursement for the delivery of a code of SRT.
Technology AdoptionThe newly published CPT codes for SRT treatment of nonmelanoma skin cancer enhance physician economics and broaden adoption of the technology.
Bears Say
Reimbursement LimitationsA proposed Local Coverage Determination to limit the reimbursement for ultrasound has a negative impact on topline sales since May 2025.
Revenue DeclineTotal revenue was $7.3M, representing 21% YoY decline and missing our projection of $8.3M.
Sales ExpectationsRevenue and gross margin estimates for 2025 and 2026 have been lowered due to expectations of lower SRT system sales.
Sensus Healthcare News
SRTS FAQ
What was Sensus Healthcare, Inc.’s price range in the past 12 months?
Sensus Healthcare, Inc. lowest stock price was $3.03 and its highest was $9.33 in the past 12 months.
What is Sensus Healthcare, Inc.’s market cap?
Sensus Healthcare, Inc.’s market cap is $69.05M.
When is Sensus Healthcare, Inc.’s upcoming earnings report date?
Sensus Healthcare, Inc.’s upcoming earnings report date is Feb 05, 2026 which is in 86 days.
How were Sensus Healthcare, Inc.’s earnings last quarter?
Sensus Healthcare, Inc. released its earnings results on Nov 06, 2025. The company reported -$0.06 earnings per share for the quarter, beating the consensus estimate of -$0.095 by $0.035.
Is Sensus Healthcare, Inc. overvalued?
According to Wall Street analysts Sensus Healthcare, Inc.’s price is currently Undervalued.
Does Sensus Healthcare, Inc. pay dividends?
Sensus Healthcare, Inc. does not currently pay dividends.
What is Sensus Healthcare, Inc.’s EPS estimate?
Sensus Healthcare, Inc.’s EPS estimate is -0.06.
How many shares outstanding does Sensus Healthcare, Inc. have?
Sensus Healthcare, Inc. has 16,440,037 shares outstanding.
What happened to Sensus Healthcare, Inc.’s price movement after its last earnings report?
Sensus Healthcare, Inc. reported an EPS of -$0.06 in its last earnings report, beating expectations of -$0.095. Following the earnings report the stock price went up 19.318%.
Which hedge fund is a major shareholder of Sensus Healthcare, Inc.?
Among the largest hedge funds holding Sensus Healthcare, Inc.’s share is Sheaff Brock Investment Advisors LLC. It holds Sensus Healthcare, Inc.’s shares valued at 0.
Sensus Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$7.33 (108.24% Upside)
$7.33 (108.24% Upside)
Blogger Sentiment
Bullish
SRTS Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 40.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $3.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.4%
Last 30 Days ▲ 0.3%
Last 30 Days ▲ 0.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.77%
12-Months-Change
Fundamentals
Return on Equity
-5.71%
Trailing 12-Months
Asset Growth
-2.61%
Trailing 12-Months
Company Description
Sensus Healthcare, Inc.
Sensus Healthcare (SRTS) is a medical technology company that specializes in innovative solutions for the treatment of skin cancer and other dermatological conditions. The company primarily focuses on developing and marketing non-invasive therapies, including its flagship product, the Sensus SRT-100, which utilizes superficial radiation therapy for effective treatment. Sensus Healthcare operates in the healthcare sector, targeting dermatologists, oncologists, and healthcare facilities to enhance patient care and treatment outcomes.
SRTS Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive and negative aspects. While there were significant achievements such as the introduction of dedicated CPT codes, growth in treatment volumes, and a strong cash position, these were offset by decreased revenues, lower gross margins, increased operating expenses, and a net loss for the quarter.View all SRTS earnings summariesSRTS Stock 12 Month Forecast
Average Price Target
$7.33
▲(108.24% Upside)
Technical Analysis
Ownership Overview
1.74% Insiders
9.20% Mutual Funds
0.40% Other Institutional Investors
83.25% Public Companies and
Individual Investors